Company: Takeda Pharmaceutical Co. Ltd.
Job title: LBx Strategy Lead, Companion Diagnostics
Chair’s Opening Remarks 8:40 am
day: Day Two
Panel Discussion on Equity, Diversity & Inclusion (ED&I): Expediting Liquid Biopsy Development & Validation for Early Screening to Advance Equity in Personalized Treatment 9:30 am
What strategies can be implemented to address disparities in early cancer screening using liquid biopsies? What steps are being taken to validate liquid biopsy assays across diverse patient populations, considering variations in genetic and molecular profiles, to tailor inclusive personalized treatment strategies? How to promote diversity and inclusion in research related to liquid biopsy development…Read more
day: Day One